Evidence map›Paper›PMID 33106792›Full record

ArticleJACC. Case reports2020

Right and Left-Sided Carcinoid Heart Disease in the Setting of Selective Serotonin Reuptake Inhibitor Use.

Jennifer Bell, Maad Alhudairy, Vera Kazakova, Michael Johnstone, Lana Tsao

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JACC. Case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Cardiac Roles of Serotonin (5-HT) and 5-HT-Receptors in Health and Disease.International journal of molecular sciences · 2023
    Review
  3. The Thickened Valve.JACC. Case reports · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jennifer BellDivision of Cardiovascular Medicine, St. Elizabeth's Medical Center, Brighton, Massachusetts.
Maad AlhudairyDepartment of Medicine, St. Elizabeth's Medical Center, Brighton, Massachusetts.
Vera KazakovaDepartment of Medicine, St. Elizabeth's Medical Center, Brighton, Massachusetts.
Michael JohnstoneDivision of Cardiovascular Medicine, St. Elizabeth's Medical Center, Brighton, Massachusetts.
Lana TsaoDivision of Cardiovascular Medicine, St. Elizabeth's Medical Center, Brighton, Massachusetts.
St. Elizabeth's Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carcinoid heart disease is a complication of carcinoid syndrome. The role of selective serotonin reuptake inhibitors in carcinoid heart disease is unclear. We present a case of refractory heart failure due to right- and left-sided carcinoid heart disease in the setting of selective serotonin reuptake inhibitor use despite remission of carcinoid syndrome. (

Indexed as

5-HT, 5-hydroxytryptamine receptorcarcinoid heart diseasecarcinoid syndromeCHD, carcinoid heart diseaseCS, carcinoid syndromeHedinger syndromeNET, neuroendocrine tumorSSRI, selective serotonin reuptake inhibitorvalvular disease

Identifiers

PMID33106792
PMCPMC7577728
OpenAlexW3094410553

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.